Silent Brain Infarction After Endovascular Arch Procedures

NCT04489277 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 91

Last updated 2020-08-06

No results posted yet for this study

Summary

This is the largest study to evaluate incidence and distribution of silent cerebral infarction (SBI) following endovascular repair for disease of the aortic arch. Also, it is the first cohort to include total endovascular arch repair and devices flushed with carbon dioxide (CO2) to prevent gaseous cerebral embolization.

Conditions

  • Aortic Arch Aneurysm

Interventions

DEVICE

Endovascular Arch Procedures

Endovascular Arch Procedures (TEVAR, Branch endografts, Fenestrated endografts)

Sponsors & Collaborators

  • Fondation Hôpital Saint-Joseph

    collaborator OTHER
  • Universitätsklinikum Hamburg-Eppendorf

    collaborator OTHER
  • Vascular Surgical Research Group, Imperial College, London, UK

    collaborator UNKNOWN
  • Sanger Heart and Vascular Institute, Charlotte, NC

    collaborator UNKNOWN
  • Loyola University Medical Center, Maywood, IL

    collaborator UNKNOWN
  • UAB School of Medicine, Birmingham, AL

    collaborator UNKNOWN
  • Heidelberg University Hospital, Heidelberg, Germany

    collaborator UNKNOWN
  • University Hospital of Freiburg, Freiburg, Germany

    collaborator UNKNOWN
  • Stanford University

    collaborator OTHER
  • Massachusetts General Hospital

    collaborator OTHER
  • Baylor Research Hospital, Dallas, TX

    collaborator UNKNOWN
  • Emory University Hospital, Atlanta, GA

    collaborator UNKNOWN
  • University Hospital of Mainz, Mainz, Germany

    collaborator UNKNOWN
  • Diakonie Hospital Jung-Stilling, Siegen, Germany

    collaborator UNKNOWN
  • Mayo Clinic, Rochester, MN

    collaborator UNKNOWN
  • Sentara Vascular/Eastern Virginia Medical School, Norfolk, VA

    collaborator UNKNOWN
  • Maastricht University Medical Centre, Maastricht, Netherlands

    collaborator UNKNOWN
  • I.R.C.C.S. Policlinico San Donato, San Donato Milanese, Italy

    collaborator UNKNOWN
  • Memorial Care Long Beach Heart & Vascular Institute, Long Beach, CA

    collaborator UNKNOWN
  • Medical University of Vienna

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2020-01-31
Completion
2020-01-31

Countries

  • France
  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04489277 on ClinicalTrials.gov